Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D)

Clinical trial NCT04905823 · COMPLETED

Trial details

NCT number: NCT04905823
Sponsor: Paolo Fiorina, MD
Status: COMPLETED
Study type: OBSERVATIONAL

Type 1 Diabetes

Start date: 2021-03-31
Primary completion: 2021-12-31
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.